NEURONTIN
Generic: GABAPENTIN
Parke-Davis Div of Pfizer IncManufacturer
ORALRoute
GABAPENTINActive Substance
1993-12-30Original Approval
NEURONTIN is FDA application NDA020235, sponsored by VIATRIS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
29,450 reports
2
FATIGUE
24,893 reports
3
NAUSEA
22,637 reports
4
PAIN
21,112 reports
5
OFF LABEL USE
19,651 reports
6
DIARRHOEA
18,062 reports
7
HEADACHE
17,805 reports
8
DIZZINESS
16,124 reports
9
FALL
15,473 reports
10
DYSPNOEA
14,194 reports